Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
188.4 INR | +1.10% | -5.89% | -9.16% |
09/05 | Transcript : Nath Bio-Genes Limited, Q4 2024 Earnings Call, May 09, 2024 | |
08/05 | Nath Bio-Genes Limited Recommends Dividend for Financial Year 2023-24 | CI |
Sales 2022 | 2.78B 33.38M | Sales 2023 | 3.01B 36.14M | Capitalization | 2.68B 32.19M |
---|---|---|---|---|---|
Net income 2022 | -673M -8.07M | Net income 2023 | 350M 4.2M | EV / Sales 2022 | 1.78 x |
Net Debt 2022 | 888M 10.65M | Net Debt 2023 | 672M 8.06M | EV / Sales 2023 | 1.11 x |
P/E ratio 2022 |
-6.02
x | P/E ratio 2023 |
7.67
x | Employees | 433 |
Yield 2022 |
0.94% | Yield 2023 |
1.42% | Free-Float | 38.47% |
Latest transcript on Nath Bio-Genes (India) Limited
1 day | +1.10% | ||
1 week | -5.89% | ||
Current month | -8.68% | ||
1 month | -3.73% | ||
3 months | -11.72% | ||
6 months | -4.73% | ||
Current year | -9.16% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 64 | 30/99/30 | |
Director of Finance/CFO | 63 | - | |
Compliance Officer | 30 | 31/18/31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 64 | 30/99/30 | |
Director/Board Member | 60 | 10/12/10 | |
Director/Board Member | 42 | 30/15/30 |
Date | Price | Change | Volume |
---|---|---|---|
15/24/15 | 188.4 | +1.10% | 41,141 |
14/24/14 | 186.4 | +0.24% | 48,848 |
13/24/13 | 185.9 | -1.93% | 37,601 |
10/24/10 | 189.6 | -2.07% | 62,212 |
09/24/09 | 193.6 | -5.29% | 73,531 |
Delayed Quote NSE India S.E., May 15, 2024 at 05:13 pm IST
More quotes1st Jan change | Capi. | |
---|---|---|
-9.16% | 42.41M | |
+15.06% | 3.37B | |
-95.58% | 1.61B | |
-2.28% | 1.57B | |
-0.81% | 1.28B | |
-7.60% | 1.24B | |
-11.30% | 1.23B | |
-.--% | 1.22B | |
0.00% | 1.2B | |
-7.89% | 1.17B |
- Stock Market
- Equities
- NATHBIOGEN Stock